Add BrightSurf on Google Email

Thyroid lobectomy vs. total thyroidectomy in indeterminate molecular risk thyroid cancer: A randomized clinical trial

The study aimed to determine the proportion of eligible patients consenting to either thyroid lobectomy or total thyroidectomy. It found that 93.5% of patients who would consent to randomization completed the assigned surgery. The results provide valuable insights for targeting enrollment in future multicenter trials.

SourceJAMA Network·JournalJAMA Otolaryngology–Head & Neck Surgery·DateAug 20, 2026

ESE and ESPE launch joint transition of care guidance to improve outcomes for young people moving from child to adult endocrine care

The ESE and ESPE have launched a landmark Joint Clinical Practice Guidance to support structured and effective transition of young people with endocrine conditions. The Guidance provides practical, evidence-based recommendations to ensure continuity, safety and quality of care during this critical phase in a patient's life.

New EndoCompass Research Roadmap calls for coordinated investment to tackle Europe’s hormone health challenge

The European Society of Endocrinology has released the EndoCompass Research Roadmap, a major new initiative to align research efforts and improve funding strategies for hormone-related health challenges. The roadmap identifies specific research needs across eight endocrine specialties and five cross-cutting areas.

SourceEuropean Society of Endocrinology·TypeCommentary/editorial·DateOct 17, 2025

Robot faster than physicians at spotting side effects

A new study at the University of Gothenburg found that a software robot can detect side effects faster than physicians during amiodarone treatment for cardiac arrhythmia. The robot also recommends appropriate intervals between lab tests, aligning with standard practices and reducing unnecessary testing.

SourceUniversity of Gothenburg·JournalJournal of Medical Internet Research·TypeComputational simulation/modeling·DateFeb 18, 2025

Pioneering neuroendocrinologist shapes brain research at 100 while still making discoveries

Dr. Seymour Reichlin's centennial celebration highlights his ongoing scientific impact, with recent collaborations yielding new insights into hormone therapies for cognitive enhancement and emotional homeostasis. His work has established neuroendocrinology as a distinct field, bridging neuroscience, endocrinology, and clinical medicine.

SourceGenomic Press·JournalBrain Medicine·TypeNews article·DateDec 3, 2024

Boston Medical Center and Boston University researchers one step closer to developing cell-based therapy for hypothyroidism

Boston Medical Center and Boston University researchers have made a breakthrough in developing cell-based therapy for hypothyroidism. They derived transplantable thyroid follicular epithelial cells from human induced pluripotent stem cells, which can be transplanted into thyroid-deficient animal models.

SourceBoston Medical Center·JournalStem Cell Reports·DateNov 7, 2024

Carnegie Mellon to lead development of implantable cell-based bioelectronic devices for patient-specific treatment and disease monitoring

A Carnegie Mellon-led team has secured a $42 million grant to develop implantable, cell-based bioelectronic devices for real-time therapy and disease monitoring in patients with thyroid disorders. The devices will offer adjustable, low-cost treatment and continuous biomarker measurement.

How thyroid hormone fuels the drive to explore

Researchers at Harvard Medical School discovered that thyroid hormone changes brain wiring to drive exploratory behavior, which is essential for survival during seasonal changes. The study found a link between thyroid hormone levels and metabolic rates, shedding light on the hormone's role in modulating behavior.

SourceHarvard Medical School·JournalCell·TypeExperimental study·DateAug 22, 2024

Controlling lipid levels with less side effects possible with new drug

Scientists have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ) to treat lipid disorders. Mice administered the drug showed decreased lipid levels in the liver and blood with fewer side effects compared to existing compounds.

SourceInstitute of Transformative Bio-Molecules (ITbM), Nagoya University·JournalCommunications Medicine·TypeExperimental study·DateAug 6, 2024

Subclinical hypothyroidism in early pregnancy associated with more than quadrupled risk of reduced thyroid function within 5 years of delivery

A new study found that subclinical hypothyroidism before 21 weeks of pregnancy is associated with a more than quadrupled risk of overt hypothyroidism or thyroid replacement therapy within 5 years of delivery. Individuals with higher levels of antibodies against a thyroid enzyme were also at increased risk.

SourceUniversity of Utah Health·JournalThyroid·TypeRandomized controlled/clinical trial·DateAug 2, 2024

New genetic mutation identified for congenital thyroid condition

A team of researchers from the University of Chicago has identified a genetic mutation in a non-coding region of DNA that alters thyroid hormone regulation, leading to a rare form of congenital thyroid abnormality. This discovery sheds light on a previously unexplained phenomenon and may lead to new treatments for individuals with this...

SourceUniversity of Chicago·JournalNature Genetics·TypeExperimental study·DateMay 7, 2024

People with hypothyroidism and type D personality may be more likely to experience poor treatment outcomes

Researchers discovered that people with hypothyroidism are more likely to have a type D personality, which is characterized by pessimism and negative emotions. Those with both conditions experienced high levels of anxiety, depression, and dissatisfaction with treatment, highlighting the need for further research to improve outcomes.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateApr 9, 2024

Hope for full recovery as researchers successfully regenerate thyroid glands in the spleen

A recent study published in Advanced Science has successfully regenerates thyroid glands in the spleen, restoring hormone levels and physiological homeostasis in mice with total thyroidectomy. The innovative approach leverages the spleen's unique properties to create a favorable environment for thyroid regeneration.

SourceNanjing University School of Life Sciences·JournalAdvanced Science·TypeExperimental study·DateDec 12, 2023

Anti-rheumatic drugs could prevent thyroid disease

Researchers found that immunomodulatory drugs used to treat rheumatoid arthritis can reduce the risk of autoimmune thyroid diseases. Patients treated with these drugs had a 46% lower risk of developing an autoimmune thyroid disease compared to those without rheumatoid arthritis.

SourceKarolinska Institutet·JournalJournal of Internal Medicine·TypeObservational study·DateNov 22, 2023

The incredible journey of clownfish larvae: Mini athletes, maximum performance

Researchers investigated the role of thyroid hormones in coordinating the metamorphosis of clownfish, discovering a strong interaction between metabolic processes and hormone regulation. Thyroid hormones play a critical role in timing the transformation and supporting energy demands during the journey.

SourceOkinawa Institute of Science and Technology (OIST) Graduate University·JournalCell Reports·TypeExperimental study·DateJul 11, 2023

Researchers identify potential new strategy to prevent side effects from immunotherapy

Researchers at UCLA Jonsson Comprehensive Cancer Center have found a potential therapeutic target, IL-21, to reduce endocrine autoimmune side effects from checkpoint immunotherapy. A specific group of immune cells play a central role in this autoimmune attack and blocking IL-21 prevents thyroid autoimmunity.

SourceUniversity of California - Los Angeles Health Sciences·JournalScience Translational Medicine·DateMay 17, 2023

BU study: no significant differences in mortality, adverse events in patients taking thyroid medications

A recent study from Boston University School of Medicine found no significant differences in mortality among patients treated with propylthiouracil (PTU) or methimazole (MMI) for thyroid storm. The researchers compared the two drugs using a national database of hospitalization data and found no significant differences between the groups.

SourceBoston University School of Medicine·JournalJAMA Network Open·TypeObservational study·DateApr 18, 2023

Keck School of Medicine study finds “forever chemicals” disrupt key biological processes

A Keck School of Medicine study found exposure to PFAS, known as 'forever chemicals,' disrupts key biological processes in children and young adults, increasing risk of diseases such as developmental disorders, cardiovascular disease, and cancer. The study highlights the importance of regulating PFAS as a class of chemicals.

SourceKeck School of Medicine of USC·JournalEnvironmental Health Perspectives·TypeExperimental study·DateFeb 22, 2023

Mild thyroid disorders can cause severe heart problems

Researchers discovered that mild thyroid dysfunctions can lead to serious heart issues, with elevated free T4 levels increasing cardiovascular mortality. A systematic review of 32 studies found a direct correlation between FT4 concentrations and cardiac death, paving the way for personalized preventive care.

SourceRuhr-University Bochum·JournalFrontiers in Cardiovascular Medicine·TypeMeta-analysis·DateOct 24, 2022

COVID-19 vaccination appears to be safe for patients treated for hypothyroidism

A new study presented at ENDO 2022 found that inactivated and mRNA COVID-19 vaccines do not cause significant fluctuations in thyroid function or increase the risk of emergency department visits among patients treated for hypothyroidism. The research suggests that these vaccines can be a safe option for this vulnerable population.

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateJun 11, 2022

Newly discovered effect of toxic goiter on brain

Researchers discovered that toxic goiter causes shrinkage in central brain regions, such as the hippocampus and amygdala, which can lead to mental symptoms. The study provides key insights for patients with Graves' disease, a common form of hyperthyroidism.

SourceUniversity of Gothenburg·JournalThe Journal of Clinical Endocrinology and Metabolism·TypeRandomized controlled/clinical trial·DateFeb 8, 2022

CHOP researchers define a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior

Researchers at Children's Hospital of Philadelphia define a 3-tiered molecular classification system for pediatric differentiated thyroid cancer, where fusion oncogenes are associated with more invasive disease and lower remission rates. The study contrasts findings from adults, who have a two-tiered system based on BRAF mutations.

SourceChildren's Hospital of Philadelphia·JournalJournal of Clinical Oncology·DateJan 31, 2022

Abnormal thyroid hormone levels during pregnancy may increase the risk of preschool boys’ behavioral problems

A study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that abnormal thyroid hormone levels during pregnancy may predict preschool boys' emotional and behavioral problems. Mothers with high thyroid hormone levels were more likely to have withdrawn, anxious, or depressed sons.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJan 6, 2022

Thyroid cancer now diagnosed with machine learning-powered photoacoustic/ultrasound imaging

Researchers have developed a non-invasive method to diagnose thyroid cancer using photoacoustic and ultrasound image technology combined with artificial intelligence. The technique accurately classifies malignant nodules with high sensitivity and specificity, reducing unnecessary biopsies and medical costs.

Exposure to flame retardants early in pregnancy linked to premature birth

A new study has found a link between early exposure to flame retardants and an increased risk of premature birth in pregnant women. Women with high levels of polybrominated diphenyl ethers (PBDEs) in their blood were more likely to deliver their babies early, with no such association seen for those with lower exposure levels.

SourceNYU Langone Health / NYU Grossman School of Medicine·JournalJournal of Perinatal Medicine·DateMar 25, 2021